Insider Notice: Susan Kronick Plans Sale of 1,600 Hyatt Shares
Rhea-AI Filing Summary
Hyatt Hotels Corporation (H) Form 144 notifies the SEC of a proposed sale of 1,600 common shares by the account of Susan D. Kronick. The shares are held through Morgan Stanley Smith Barney LLC and the filing lists an aggregate market value of $230,848 based on outstanding shares of 42,337,031 and an approximate sale date of 09/02/2025 on the NYSE.
The securities were originally acquired as restricted stock units on 05/13/2015 from the issuer. The filer also reported earlier 10b5-1 sales by the same person on 06/10/2025 totaling 1,600 shares for $216,000 gross proceeds. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Filing includes complete acquisition details (RSU grant date 05/13/2015) which supports Rule 144 compliance
- Broker and exchange are identified (Morgan Stanley Smith Barney LLC; NYSE), enabling transparent execution
Negative
- No information on whether sales are subject to any lock-up or company-specific transfer restrictions
- Filer did not specify whether the planned sale is part of a standing 10b5-1 plan (no plan adoption date provided)
Insights
TL;DR: Routine insider sale filing for 1,600 shares under Rule 144; prior 10b5-1 sale occurred in June 2025.
The Form 144 documents a proposed sale by an insider or affiliate using a broker, specifying the security type, amount, acquisition details, and market values required for Rule 144 compliance. Key compliance elements present: acquisition date and nature (RSUs 05/13/2015), broker information, exchange (NYSE), and the seller's representation about material non-public information. The filing also discloses a prior 10b5-1 execution on 06/10/2025 of an identical share amount, which is relevant for aggregation and timing assessments under resale rules. No disclosures here indicate unusual restrictions, pledges, or financing arrangements that would complicate resale mechanics.
TL;DR: Small, routine sale relative to outstanding shares; not likely material to shareholders.
The size of the proposed sale (1,600 shares, ~$230.8k market value) is negligible versus the issuer's reported outstanding shares (42,337,031), suggesting limited market impact. Acquisition via restricted stock units dated 2015 shows these were vested awards rather than open-market purchases. The inclusion of broker and planned sale date supports an orderly disposition. The earlier 10b5-1 sale with gross proceeds of $216,000 is consistent with periodic planned selling activity rather than an ad hoc large disposition.